ANMIR AGRESAR-DONATE: Open Payments
NPI 1285832865 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 15 payments from 5 companies in 2025. Trend: 2023 $241 · 2024 $210 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $154 |
| Janssen Pharmaceuticals, Inc | 3 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across MA — which companies pay providers there.
